| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ROKA BIOSCIENCE INC | 250,000 | 650,000 | 0.05% | ||
| 2 | IMMUNE DESIGN CORP | 55,000 | 1,136,000 | 0.08% | ||
| 3 | Vical Inc | 1,829,088 | 1,280,000 | 0.09% | ||
| 4 | PUMA BIOTECHNOLOGY | 11,000 | 1,284,000 | 0.09% | ||
| 5 | SCYNEXIS INC | 176,000 | 1,547,000 | 0.11% | ||
| 6 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 75,000 | 1,589,000 | 0.12% | ||
| 7 | KINDRED BIOSCIENCES INC | 275,000 | 1,876,000 | 0.14% | ||
| 8 | XENOPORT INC | 325,000 | 1,992,000 | 0.15% | ||
| 9 | TETRAPHASE PHARMACEUTICALS INC COM | 43,000 | 2,040,000 | 0.15% | ||
| 10 | PTC THERAPEUTICS INC | 43,000 | 2,070,000 | 0.15% | ||
| 11 | INFINITY PHARMACEUTICALS INC | 215,000 | 2,354,000 | 0.17% | ||
| 12 | DYAX CORP COM CVR | 102,500 | 2,716,000 | 0.20% | ||
| 13 | CERULEAN PHARMA INC | 625,000 | 2,875,000 | 0.21% | ||
| 14 | FIVE PRIME THERAPEUTICS INC | 120,000 | 2,981,000 | 0.22% | ||
| 15 | CIDARA THERAPEUTICS INC | 250,000 | 3,505,000 | 0.26% | ||
| 16 | ILLUMINA INC | 17,750 | 3,876,000 | 0.28% | ||
| 17 | ANTHERA PHARMACEUTICALS I | 470,000 | 4,051,000 | 0.30% | ||
| 18 | BIODEL INC | 4,000,000 | 4,120,000 | 0.30% | ||
| 19 | Ascendis Pharma | 240,000 | 4,243,000 | 0.31% | ||
| 20 | ATHENA HEALTH INC. | 38,000 | 4,354,000 | 0.32% | ||
| 21 | DERMIRA INC COM | 250,001 | 4,388,000 | 0.32% | ||
| 22 | BIOMARIN PHARMACEUTICAL INC | 32,500 | 4,445,000 | 0.32% | ||
| 23 | FIBROGEN INC | 190,000 | 4,465,000 | 0.33% | ||
| 24 | ARATANA THERAPEUTICS INC | 300,000 | 4,536,000 | 0.33% | ||
| 25 | JAZZ PHARMACEUTICALS PLC | 26,000 | 4,578,000 | 0.33% | ||
| 26 | PACIRA PHARMACEUTICALS INC | 68,000 | 4,809,000 | 0.35% | ||
| 27 | RAPTOR PHARMACEUTICAL CORP | 305,000 | 4,816,000 | 0.35% | ||
| 28 | CERNER CORP | 70,000 | 4,834,000 | 0.35% | ||
| 29 | Intersect ENT Inc | 175,000 | 5,010,000 | 0.37% | ||
| 30 | WELLCARE HEALTH PLANS INC | 60,000 | 5,090,000 | 0.37% | ||
| 31 | CHINA CORD BLOOD CORP | 830,000 | 5,113,000 | 0.37% | ||
| 32 | MACROGENICS INC | 137,500 | 5,221,000 | 0.38% | ||
| 33 | ALLERGAN PLC | 5,000 | 5,228,000 | 0.38% | ||
| 34 | INSYS THERAPEUTICS INC NEW COM NEW | 147,000 | 5,280,000 | 0.39% | ||
| 35 | AMICUS THERAPEUTICS INC COM | 377,500 | 5,342,000 | 0.39% | ||
| 36 | REGENERON PHARMACEUTICALS | 11,000 | 5,611,000 | 0.41% | ||
| 37 | TANDEM DIABETES CARE INC COM | 535,000 | 5,799,000 | 0.42% | ||
| 38 | CARDIOME PHARMA CORP | 625,000 | 5,881,000 | 0.43% | ||
| 39 | INVITAE CORP | 400,000 | 5,952,000 | 0.43% | ||
| 40 | ASSEMBLY BIOSCIENCES INC | 313,500 | 6,038,000 | 0.44% | ||
| 41 | Theravance Biopharma Inc | 475,000 | 6,185,000 | 0.45% | ||
| 42 | CASTLIGHT HEALTH INC COM CL B | 800,000 | 6,512,000 | 0.48% | ||
| 43 | NOVADAQ TECHNOLOGIES INC | 540,000 | 6,539,000 | 0.48% | ||
| 44 | CONNECTURE INC | 625,000 | 6,600,000 | 0.48% | ||
| 45 | Wuxi Pharmatech Inc ADR | 168,000 | 7,100,000 | 0.52% | ||
| 46 | IDEXX LAB | 111,000 | 7,120,000 | 0.52% | ||
| 47 | KITE PHARMA INCORPORATED | 118,000 | 7,194,000 | 0.53% | ||
| 48 | EPIZYME INC COM | 306,500 | 7,356,000 | 0.54% | ||
| 49 | Otonomy Inc | 320,800 | 7,375,000 | 0.54% | ||
| 50 | Life Technologies Corp | 408,496 | 7,565,000 | 0.55% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-15-001627, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
